Fundraising FoxBreakthrough Victoria — 2024 Investments
5 investments dated 2024 · listed companies and verified rows first · show all
Aravax is a clinical-stage biotechnology company developing next-generation immunotherapies to treat food allergies.
BiotechHealthtechMedical DevicesMelbourne, AU
Sara Prickett(Co-founder)in
Co-investorsBrandon CapitalNovartis Venture FundTenmileUniSeed Pty Ltd.
Additive provides a GenAI tool that extracts tax data from K-1, K-3, and related forms (including state forms, 199A, 926, and others), converting PDF tax packages into Excel workpapers or JSON via a web app, Excel add-in, or API.
AI & Machine LearningFintechSaaS
Venky Iyer(Founder)in
Co-investorsMantis CapitalACORN BIOVENTURESAM VenturesElad GilFred EhrsamImmad Akhund+2 more
Conflu-X Technology manufactures thermal management products including cold plates, intercoolers, and liquid cooling solutions for automotive, aviation, data center, defense, and industrial applications.
Advanced ManufacturingData & InfrastructureHardware
Co-investorsAM VenturesACORN BIOVENTURES
Liquid Instruments develops Moku, a reconfigurable integrated test system for complex research and development applications.
Deep TechDeveloper ToolsEnterprise SoftwareHardware
Daniel Shaddock(CEO)inDanielle Wuchenich(Chief Operating Officer)in
Co-investorsAnzu PartnersMA Growth VenturesSignificant VenturesACORN BIOVENTURESAcorn CapitalLockheed Martin Ventures
Xefco develops advanced materials and manufacturing solutions for the textile industry, with a focus on sustainable dyeing and finishing technologies.
Advanced ManufacturingCleantechNew MaterialsGeelong, AU
Tom Hussey(Founder)in
Co-investorsMain Sequence VenturesPacific ChannelVirescent Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.